Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age

BACKGROUND: Newborn screening allows novel treatments for cystic fibrosis (CF) to be trialled in early childhood before irreversible lung injury occurs. As respiratory exacerbations are a potential trial outcome variable, we determined their rate, duration and clinical features in preschool children...

Descripción completa

Detalles Bibliográficos
Autores principales: Byrnes, Catherine Ann, Vidmar, Suzanna, Cheney, Joyce L, Carlin, John B, Armstrong, David S, Cooper, Peter J, Grimwood, Keith, Moodie, Marj, Robertson, Colin F, Rosenfeld, Margaret, Tiddens, Harm A, Wainwright, Claire E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Cystic Fibrosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711493/
https://www.ncbi.nlm.nih.gov/pubmed/23345574
http://dx.doi.org/10.1136/thoraxjnl-2012-202342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711493/
https://www.ncbi.nlm.nih.gov/pubmed/23345574
http://dx.doi.org/10.1136/thoraxjnl-2012-202342

Ejemplares similares